Connect your AI

AARD AARD Operating lease liabilities

Operating lease liabilities at other companies

Viking TherapeuticsVKTX

——

ArvinasARVN

——

Protagonist TherapeuticsPTGX

——

Other financials

Income statement

Revenue-—

Operating income-$22.5M-115%

Net income-$21.6M-132%

EPS (diluted)-$0.99-39.4%

Balance sheet

Cash & equivalents$62.4M+136%

Total debt$336.0K-53.7%

Total equity$87.0M-42.3%

Total assets$98.6M-37.2%

Cash flow

Operating cash flow-$18.9M-65.7%

CapEx--100%

Free cash flow-$16.8M-117%

Valuation

Market cap$124.35M-58.6%

Enterprise value$62.25M-77.4%

Returns & leverage

Return on equity-58.8%—

Debt / equity0×0.0×

Current ratio8.1×-17.8×

Where this comes from

Reported directly by AARD in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.

The official record: AARD’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about AARD's operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is AARD's operating lease liabilities?: AARD (AARD) reported operating lease liabilities of -$105K in Q1 2026.
How has AARD's operating lease liabilities changed year-over-year?: AARD's operating lease liabilities decreased by 98.1% year-over-year, from -$53K to -$105K.